FDA Inspection
Seattle Reproductive Medicine, Inc., P.S.Seattle Reproductive Medicine, Inc., P.S. – FDA Inspection, Oct 24, 2017
Record Details
This FDA Inspection record concerns Seattle Reproductive Medicine, Inc., P.S., with an inspection on October 24, 2017, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- October 24, 2017
- Product Type
- Biologics
View Company Profile
ID · 87978760-7c8a-4f8f-9964-6f62749fb63c
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1031414
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Seattle Reproductive Medicine, Inc., P.S.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| September 16, 2025 | Not classified | Seattle District Office | |
| April 7, 2022 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 10, 2016 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| February 10, 2014 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Seattle Reproductive Medicine, Inc., P.S.
- FDA Inspection 1293422 - 2025-09-16
- FDA Inspection 1171334 - 2022-04-07
- FDA Inspection 961640 - 2016-02-10
- FDA Inspection 865541 - 2014-02-10
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.